Pharma & Healthcare
Peptide Cancer Vaccine
Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host.
- Types
- ITK-1 · GRN-1201 · TPIV200
- Applications
- Breast Cancer · Lung Cancer · Melanoma
5 editions2 January 2026